Cancilico
MyeloAID: AI-Assisted Bone Marrow Morphology
Dresden, Germany · Founded 2023 · $2.9M raised
- Headquarters
- Dresden
- Founded
- 2023
- Business Model
- B2B
- Website
- cancilico.com
- Total Funding
- $2.9M
- Last Round
- $2.9M SeedJan 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
HTGF portfolio company
Summary
Cancilico is an Artificial Intelligence company based in Dresden, Germany, founded in 2023. It has raised $2.9M in total across 1 round, most recently a $2.9M Seed round in Jan 2026.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2026
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cancilico"><img src="https://indexed.vc/api/badge/company/cancilico" alt="Cancilico on Indexed.vc" width="260" height="76" /></a>